BLUE - צמיחת הכנסות שנתית ב-12 החודשים האחרונים bluebird bio, Inc.

bluebird bio, Inc. (BLUE) monetizes unique lentiviral blood-curing therapies, which drives the trend in last twelve months (LTM) sales volume. The current value of this metric is 321.60. Revenue stability relies on flawless ultra-cold delivery of biomaterials. High scientific standing and physician trust solidify the company's position as an ethical leader in the gene therapy segment.
פילוחי נתונים אנליטיים מרוכזים עבור Bluebird Bio (BLUE)

This indicator measures the dynamics of operating income on a rolling year basis, allowing for an assessment of business model sustainability and the timely identification of stagnation risks through the trend of annual revenue growth over a rolling 12-month period. For bluebird bio, Inc. (BLUE), this metric confirms the commercial realization of pricing power within the gene therapy segment, transforming the uniqueness of medical products into a stable cash generator.